PacificoBiolabs, a pioneering company in mycelium fermentation protein production, has successfully raised €7 million in a Series A funding round. The investment round included contributions from Stray Dog Capital, TGFS, Sprout & About Ventures, Simon Capital, FoodLabs, and a regional brewery partner. The company aims to address the growing demand for sustainable protein alternatives by leveraging existing industrial infrastructure to optimize production processes. This financial backing marks a significant step towards PacificoBiolabs’ expansion goals, targeting new markets across Europe.
How Does PacificoBiolabs Utilize Brewery Tanks for Protein Production?
In a unique approach, PacificoBiolabs has opted to use standard beer brewery fermentation tanks to produce mycelium protein ingredients. This method allows the company to take advantage of existing facilities, which are currently underutilized due to declining beer and alcohol consumption across Europe. By avoiding the high costs associated with building new bioreactors, PacificoBiolabs aims to scale its production rapidly and economically.
What Challenges Does PacificoBiolabs Aim to Address With Domestic Protein Production?
The reliance on imported feed protein continues to present challenges for Europe’s supply chains, impacting environmental and geopolitical stability. PacificoBiolabs seeks to offer a homegrown alternative that not only reduces these risks but is also produced closer to consumption centers. Their strategy involves using regional industrial capacities to develop protein ingredients, which could help stabilize supply chains in the face of global uncertainties.
Historically, the heavy dependence on international sources for protein could expose the regional food systems to fluctuations in supply, price volatility, and sustainability concerns. This initiative by PacificoBiolabs follows previous attempts to create more resilient and sustainable food systems by various companies. However, many efforts faced challenges such as high production costs and the need for technological innovation. By repurposing existing infrastructure, PacificoBiolabs appears to offer a novel solution that bypasses these historical challenges.
The recent €7 million funding will be utilized to expand production capabilities in Saxony, Germany, and to grow PacificoBiolabs’ team. The investment will also facilitate the company’s commercial launches in the DACH region and Nordic Europe. Aiming for a retail presence by late 2026, the company plans to introduce its mycelium protein products to these new markets.
“By using existing brewery infrastructure, we aim to lower production costs,” stated a representative from PacificoBiolabs, exemplifying their innovative use of resources.
This approach is designed to bring the cost of mycelium protein closer to the price of conventional meat products, making sustainable alternatives more accessible to a broader consumer base.
Another spokesperson from the company mentioned,
“Our focus is on utilizing regional capacity to ensure a stable and sustainable supply chain.”
This strategy not only supports local economies but also aligns with broader goals of reducing environmental impacts associated with transportation and production.
PacificoBiolabs’ recent funding and strategic plans highlight a shift towards smarter, more sustainable food production methods using existing resources. As the company continues to expand, it might well influence a broader trend in the food industry, encouraging more companies to explore similar infrastructure-based strategies for efficiency and cost-effectiveness.
